share_log

OpGen Analyst Ratings

Benzinga ·  Aug 14, 2023 06:41
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/14/2023 HC Wainwright & Co. Downgrades Buy → Neutral
07/20/2023 1071.42% HC Wainwright & Co. → $3 Reiterates Buy → Buy
06/26/2023 1071.42% HC Wainwright & Co. → $3 Reiterates Buy → Buy
06/21/2023 1071.42% HC Wainwright & Co. → $3 Reiterates Buy → Buy
05/16/2023 1071.42% HC Wainwright & Co. → $3 Reiterates Buy → Buy
05/13/2022 1071.42% HC Wainwright & Co. $4 → $3 Maintains Buy
03/02/2021 2633.31% Alliance Global Partners $5.65 → $7 Maintains Buy

What is the target price for OpGen (OPGN)?

The latest price target for OpGen (NASDAQ: OPGN) was reported by HC Wainwright & Co. on August 14, 2023. The analyst firm set a price target for $0.00 expecting OPGN to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for OpGen (OPGN)?

The latest analyst rating for OpGen (NASDAQ: OPGN) was provided by HC Wainwright & Co., and OpGen downgraded their neutral rating.

When is the next analyst rating going to be posted or updated for OpGen (OPGN)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OpGen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OpGen was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.

Is the Analyst Rating OpGen (OPGN) correct?

While ratings are subjective and will change, the latest OpGen (OPGN) rating was a downgraded with a price target of $0.00 to $0.00. The current price OpGen (OPGN) is trading at is $0.26, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment